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Impact of DYRK1A Haploinsufficiency on 
Facial Morphology using Three-Dimensional 
Morphometric Analysis
By: Stefani Hammond
Faculty Mentor: Dr. Lana Willians
UCF Department of Anthropology
ABSTRACT: Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A) is a gene present on 
human chromosome 21. Previous research suggests that this gene plays a developmental role in facial morphology. We 
hypothesize that individuals with DYRK1A haploinsufficiency have altered facial morphology with potentially unique 
patterns of facial variation. To assess this hypothesis, we acquired three-dimensional (3D) photogrammetric facial 
images of individuals with and without DYRK1A haploinsufficiency, and we measured anatomical landmarks to carry 
out Euclidean Distance Matrix Analysis (EDMA) and to evaluate global and local morphological differences. Our 
results show unique patterns of variation between individuals with DYRK1A haploinsufficiency and normal siblings, 
as well as unrelated normal controls, supporting our hypothesis. These results identify exactly how and where DYRK1A 
haploinsufficiency changes patterns of facial morphology. Additionally, these results may have clinical relevance by 
identifying regions of the face that can benefit from early developmental interventions, therapeutic measures, or 
potentially plastic surgery. 
KEYWORDS: DYRK1A; haploinsufficiency; biological anthropology; morphometrics
Republication not permitted without written consent of the author. 
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INTRODUCTION
Dual-specificity tyrosine-(Y)-phosphorylation regulated 
kinase 1A (DYRK1A) is a gene located on human 
chromosome 21 in the region 21qa22.2 which produces 
the DYRK1A protein kinase (Fotaki et al., 2002; Singh 
& Lauth, 2017). The function of the DYRK1A protein 
is highly dependent on the dosage of the DYRK1A gene 
(Singh & Lauth, 2017). The DYRK1A protein has roles in 
many crucial cellular functions, including the regulation 
of cell life cycles, cell proliferation, differentiation, gene 
transcription and expression, and phosphorylation 
of other proteins (Soppa & Becker, 2015; Yoshida, 
2008). Its expression in mammals is strongest during 
embryonic stages and decreases during postnatal periods, 
reaching its lowest levels during adulthood (Tejedor & 
Hämmerle, 2010; Yabut, Domogauer & D'Arcangelo, 
2010). Expression in early postnatal stages is strongest 
in the central nervous system and the heart, while also 
affecting neural system development (Fernández-
Martínez, Zahonero & Sánchez-Gómez, 2015). In the 
brain and nervous system, the protein is most expressed 
in areas controlling motor function (Dierssen & de 
Lagrán, 2006). In addition, DYRK1A has recently been 
proposed as the candidate gene for Autism Spectrum 
Disorder (ASD) and Intellectual Disability (ID) (Dang 
et al., 2017; van Bon et al., 2015).
While overexpression of DYRK1A in Trisomy 21 
is characteristic of those with Down Syndrome, 
underexpression of DYRK1A, also known as DYRK1A 
haploinsufficiency, is caused by a partial or complete 
deletion of one copy of DYRK1A. Mammals without a 
functional copy of DYRK1A often die during prenatal 
development in the organogenesis period, possibly due 
to delayed organ growth and poor embryonic blood 
circulation (Fotaki et al., 2002). Most studies investigating 
this condition have used transgenic mice models with 
a focus on quantifiable changes in brain size, neural 
development, and impact on spatial reasoning (Arqué 
et al., 2008; Fotaki et al., 2002; Tejedor & Hämmerle, 
2010). Studies involving human models for the condition 
are often case studies describing phenotypic variations 
of patients diagnosed with DYRK1A mutations. These 
phenotypic variations include deep set eyes, large or 
dysplastic ears, pointed nasal tip, long or flat philtrum, 
thin upper lip, and micrognathia (Bronicki et al., 2015; 
Ruaud et al., 2015; Ji et al., 2015). These variations, 
however, have not yet been quantified in human models.
The purpose of this study was to use three-
dimensional (3D) images to assess whether the distinct 
facial morphology of those affected by DYRK1A 
haploinsufficiency is specific to the condition. We 
hypothesize that DYRK1A haploid individuals will 
exhibit fewer significant morphological differences when 
compared to euploid siblings than in comparisons to 
the unrelated euploid group. We also expect DYRK1A 
haploid individuals to exhibit more differences compared 
to both the euploid sibling and euploid control samples 
than are observed between the euploid sibling and 
euploid control. Through these comparisons, we expect 
to reveal patterns of dysmorphologies exclusive to 
the condition by identifying specific linear distances 
(LDs) that significantly differ in comparisons between 
DYRK1A haploid individuals, euploid siblings, and 
euploid controls.
METHODS AND MATERIALS
This study uses a small sample study design to analyze 
photogrammetric surface images of: 1) children with 
DYRK1A haploinsufficiency (hereafter referred to as the 
DYRK1A Haploid sample; n = 20), 2) unaffected euploid 
siblings of individuals with DYRK1A haploinsufficiency 
(hereafter referred to as the DYRK1Asib sample; n = 11), 
and 3) unaffected unrelated normal controls (hereafter 
referred to as the EU sample; n = 120) to assess facial 
morphology. Sex ratios between samples were similar but 
not identical (sample 1: 55% female, 45% male; sample 
2: 36% female, 64% male; sample 3: 47.5% female, 52.5% 
male). Samples were also similar in age distribution 
(sample 1: range of 2-21 years of age, mean age of 10 ± 
5.87; sample 2: range of 1-18 years of age, mean age of 11 
± 5.12; sample 3: range of 1-21 years of age, mean age 11 ± 
4.70). The ethnicity for the majority of the individuals in 
each sample have either been self-identified or identified 
by a parent or guardian as Caucasian.
Photogrammetric images were previously acquired at 
local conferences and DYRK1A meetups for affected 
families using the 3dMD photogrammetric system 
3dMD Patient. Multiple images of an individual’s face 
were taken simultaneously and stitched together using 
3dMD algorithms to create a single three-dimensional 
surface (Starbuck et al. 2017). This type of technology is 
ideal for phenotypic studies due to its ability to capture 
images noninvasively, quickly, and with replicable 
precision (Aldridge, Boyadjiev, Capone, DeLeon & 
Richtsmeier, 2005; Nord et al., 2015).
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To assess measurement error of anatomical landmark 
placement, 21 anatomical soft tissue landmarks were 
collected repeatedly from ten individuals drawn randomly 
from the overall sample. Locations of landmarks and 
their corresponding labels and definitions are illustrated 
in Figure 1 and Table 1 of the Appendix. Using 3dMD 
Patient, each image was landmarked twice with at least 
24 hours between sessions to avoid memory bias. The 
overall mean measurement error for this study was 
0.065mm, which is considered sufficiently accurate for 
the purpose of this study.  
After the analysis of measurement error provided 
satisfactory results, each of the sample images was 
landmarked in two separate trials at least 24 hours apart. 
Landmarks were inspected to evaluate for gross errors 
(e.g., swapping left and right side) and then averaged 
to further minimize measurement error. Seven images 
from the DYRK1A Haploid group and three images 
from the DYRK1Asib group provided by collaborators 
were too small to landmark in 3dMD software, so an 
alternative software (Amira) was used. Afterwards, 
each individual’s anatomical landmark coordinates 
were scaled to the same centroid size using MorphoJ 
software. This process removed size variation so the LDs 
could be statistically assessed given the age variation 
and size differences of the collaborator images. Scaled 
anatomical landmark coordinates were then analyzed 
using Euclidean Distance Matrix Analysis (EDMA) 
and principal coordinates analysis (PCOORD) to assess 
local and global morphological differences.
Global patterns among samples were visualized using 
PCOORD, which summarizes and represents LD 
differences in a high-dimensional space to depict 
variation trends between samples, within samples, and 
between individuals (Bookstein, 1991; Starbuck et al., 
2017). PCOORD uses form difference matrices (FDMs) 
of individuals as opposed to sample-wide FDMs. FDMs 
of two individuals are used to compute an FΩ. An FΩ is 
calculated for every unique pair of individuals, with an 
FΩ of 0 suggesting that the two individuals have identical 
forms and FΩ increasing as the two individuals become 
more different. The FΩ for each pair is placed into a square 
matrix, which is then evaluated. The resulting values are 
used to place each individual on the axis of the resulting 
high-dimensional space. Ellipses formed by PCOORD 
analysis represent 70% confidence intervals. 
EDMA is a morphometric technique that uses landmark 
data to calculate linear distances to estimate mean form 
and mean form differences. Size and shape are quantified 
by calculating distances between all pairs of 21 landmarks, 
resulting in 210 unique LDs. A mean form matrix (FM) 
is computed to represent the mean distance between 
two landmarks across an entire sample. The FM is then 
used in a form difference matrix (FDM). The FDM uses 
ratios of mean forms of homologous LDs to quantify 
differences between samples by formatting them into 
the statistic T = max/min. The T statistic is used to test 
the null hypothesis of the LDs being identical. A T of 
one (or very close to one) would not provide sufficient 
evidence to reject the null hypothesis, while a T greater 
than 1 would provide sufficient evidence to reject the 
null hypothesis and suggest the LDs are significantly 
different (Lele, 1993; Starbuck et al., 2017). Local 
null hypotheses were evaluated using a nonparametric 
bootstrap (10,000 resamples) and confidence interval 
testing (α = 0.10). Confidence intervals were then 
provided for each LD, where confidence intervals that 
did not contain 0 were reported as significantly different 




The PCOORD scatterplot is presented in Figure 3 of 
the Appendix. The results illustrate a slight overlap of all 
three samples in multivariate shape space. There is a large 
overlap present between the EU and DYRK1Asib groups, 
while there is less overlap between the DYRK1A Haploid 
group and the DYRK1Asib and EU groups. These overlaps 
imply that the DYRK1Asib and EU groups share similar 
ranges of facial morphology, while the DYRK1A Haploid 
group differs from both the DYRK1Asib or EU samples. 
In the DYRK1A Haploid group, the larger ellipse implies 
more variation within the sample. The larger ellipse size 
of the DYRK1A Haploid group compared to the ovals of 
the two other samples also implies greater variation in 
this sample compared to the other two groups. 
EDMA Analysis
A summary of the EDMA analysis is presented in Table 
2. The DYRK1A Haploid sample had fewer significant 
differences compared to the DYRK1Asib sample than 
to the EU sample. Approximately 36.7% (77/210) 
of LDs differed between the DYRK1A Haploid and 
DYRK1Asibs samples, while 42.86% (90/210) of LDs 
differed between the DYRK1A Haploid and EU groups. 
12.1: 18-27
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The greater similarity of the DYRK1A Haploid sample 
to the DYRK1Asib sample is expected due to the implied 
genetic similarities between these groups. 8.1% (17/210) 
of LDs were significantly different between DYRK1Asibs 
and EU, which are both genetically normal.
LDs that were found to be different are visualized in 
Figure 2 of the Appendix. LDs present in the comparisons 
of DYRK1A Haploid to DYRK1Asib are largely similar to 
LDs present when comparing the DYRK1A Haploid and 
the EU group. When directly comparing the different 
LDs between the two sets of comparisons, there are 28 
LDs exclusive to the DYRK1A Haploid v. DYRK1Asib 
and DYRK1A Haploid v. EU groups. These distances can 
be attributed to the effect of DYRK1A haploinsufficiency, 
suggesting substantial differences in facial form due to 
DYRK1A haploinsufficiency. Most of these LDs are 
in the midfacial region, focused around the nose and 
philtrum.
DISCUSSION
Development of the craniofacial complex involves 
several different factors and their interactions, including 
underlying genes and prenatal environment ( Johnston 
& Bronsky, 1995; Starbuck et al. 2017). Mechanisms 
affected by these factors, which can result in craniofacial 
dysmorphologies, include brain patterning, cell migration, 
tissue fusion and bone differentiation. Cell proliferation 
and cell migration are the most common mechanisms of 
the development of craniofacial morphology (Wilkie & 
Morriss-Kay, 2001). Because a large part of the DYRK1A 
protein’s role involves cell proliferation, proper dosage 
of the DYRK1A gene is crucial for proper craniofacial 
development.
As a signaling molecule, the DYRK1A protein also affects 
the development of the neural crest, which later develops 
into embryonic facial organs (Francis-West, Ladher, 
Barlow & Graveson, 1998; Szabo-Rogers, Smithers, 
Yakob & Liu, 2010). Craniofacial development begins 
with the cranial fossae (where the brain rests within 
the skull), followed by reduction of the interorbital 
distance (distance between the eyes), and growth of 
the nasomaxillary complex (upper jaw and nasal cavity) 
(van der Meulen, Mazzola, Vermey-Keers, Strieker & 
Raphael, 1983). Many of these regions are also found 
to likely be affected by DYRK1A haploinsufficiency, 
especially those in the nasomaxillary complex. This 
finding implies that changes in dosage of DYRK1A affect 
craniofacial development beginning in its early stages.
Both the EDMA and PCOORD results support the 
conclusion that DYRK1A Haploinsufficiency affects 
facial morphology in a manner that obscures even familial 
similarities. The ellipse of the DYRK1A Haploid group in 
the PCOORD analysis is larger than the ellipses of the 
two other samples, implying more variation within the 
sample compared to the other two groups. The greater 
variation in the DYRK1A Haploid group is likely due 
to this genetic deficiency and its effect on development. 
The degree of morphological difference between the 
DYRK1A Haploid and DYRK1Asib group implies that 
despite these groups’ shared DNA, the condition affects 
craniofacial morphology to the extent what it obscures 
facial resemblance. While these changes do seem to 
obscure most familial resemblance, the fewer significant 
differences between the DYRK1Asibs sample compared 
to the EU sample imply that not all shared genetic 
resemblance is lost due to the condition.
This study’s identification of patterns of dysmorphology 
in those affected by DYRK1A haploinsufficiency support 
findings from case studies describing common traits 
found in patients with the condition, including thin 
upper lip, long philtrum, and pointed nasal tip, as these 
are found in the nasomaxillary complex. Defects affecting 
the central facial region could potentially impact quality 
of life, as organs in this region are the main mode of 
facial expression. Moreover, reconstruction in these 
areas often poses difficulties due to their complexity and 
the extent to which features are connected (Ratner & 
Levender, 2013).
While this study focuses on soft-tissue morphology 
of human models, the lack of quantifiable data in 
human models means it is difficult to support many 
conclusions presented in the current literature on this 
condition. While some comparisons can be drawn to 
quantifiable studies using mouse models, these studies 
lack information on soft tissue morphology. To develop 
a greater understanding of the extent that DYRK1A 
haploinsufficiency affects facial morphology, further 
research in human models should be conducted with 
a focus on quantitative studies on soft tissue and bone. 
Further research in mouse models with focuses on 
quantitative studies of skull morphology might also prove 
beneficial. Due to limitations in this study of relatively 
limited sample size and ethnic diversity, it would be 
advantageous for future studies to both increase sample 
size and seek out greater diversity in the sample groups.
12.1: 18-27
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Our results, based on the sheer number of facial 
differences, support our hypothesis that DYRK1A 
plays an important role in facial development. Here we 
have shown that DYRK1A expression alters soft-tissue 
morphology, but it is unknown if these changes occurred 
due to underlying bone changes or in combination 
with them. Middle and lower face morphology may be 
impacted by impaired growth and fusion of the maxillary, 
nasal, and mandibular prominences during development. 
Since skin is biologically built upon the bony scaffold of 
the skull, connective tissues may be altered by DYRK1A 
underexpression as well. Many individuals with DYRK1A 
haploinsufficiency also suffer from cognitive impairment, 
implying that brain development may also be impacted. 
Future studies should assess bone and brain morphology 
using human or animal model samples to differentiate 
and elucidate the primary and secondary effects of 
DYRK1A haploinsufficiency upon these tissues.
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APPENDIX
Figure 1. An example of landmarks placed on individual in 3dMD patient
12.1: 18-27
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Table 1. Landmark labels and their anatomical definitions
Table 2. Summary of EDMA shape analysis results. A total of 210 linear distances were statistically 
evaluated for each pairwise sample comparison.
12.1: 18-27
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Figure 2. A) Significant differences between the DYKR1A haploid and EU samples, B) Significant 
differences between the DYKK1A Haploid and DYRK1Asib samples, and C) Significant differences 
between the EU and DYRK1Asib samples. Facial images shown have been modified to remove identifiable 
features.
Figure 3.  Results from an EDMA PCOORD analysis. The farther apart two individuals along one axis, 
the greater the difference in form. In summary, 28.05% of the variance is explained by the X axis, whereas 
the Y axis explains 14.77% of the variance across the samples.
12.1: 18-27
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